Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-label, Single-arm, Multicenter Study to Evaluate the Early Effects of Abaloparatide on Tissue-based Indices of Bone Formation and Resorption

Trial Profile

An Open-label, Single-arm, Multicenter Study to Evaluate the Early Effects of Abaloparatide on Tissue-based Indices of Bone Formation and Resorption

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Oct 2018

At a glance

  • Drugs Abaloparatide (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Radius Health Inc.
  • Most Recent Events

    • 20 Aug 2018 New trial record
    • 07 Aug 2018 Status changed from planning to recruiting, as reported in the Radius Health Inc. media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top